Core Biogenesis Competitors and Similar CompaniesClear all
NextCure's competitors and similar companies include Elicio Therapeutics and Cullgen.
 NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. |  Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | |
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Beltsville, US HQ | Locations Cambridge, US HQ | Locations San Diego, US HQ Shanghai, CN Tokyo, JP |
Employees | Employees N/A | Employees 22 | Employees 4 |
Valuation ($) | Valuation ($) 39.2 m | Valuation ($) 47.5 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($55.8m) (FY, 2025) | Net income ($39.6m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 160m | Total funding raised $ 150.3m | Total funding raised $ 31m |
For sources of this data, please see the company profile
View Company Profiles
Elicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View companyCullgen
HQ
San Diego, US
Employees
4
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company